Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals Inc
WKN: A2AFXS / Symbol: CRVS / Name: Corvus / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
13,56 €
-2,31 %
Corvus Pharmaceuticals (NASDAQ:CRVS) was given a new $32.00 price target on by analysts at Oppenheimer Holdings, Inc.. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals (CRVS) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc.. They now have a $33.00 price target on the stock, up from $32.00.
Ratings data for CRVS provided by MarketBeat


Neueste Beiträge
StockNews_com in Liberty Media Corp diskutieren